The potential and limits for clinical trials for early Alzheimer's disease and some recommendations.
Schneider
L S
LS
University of Southern California Keck School of Medicine, Los Angeles, California 90033, USA. lschneid@usc.edu
D000203:Activities of Daily Living; D000544:Alzheimer Disease / Q000188:drug therapy*; D015415:Biomarkers / Q000032:analysis*; D002986:Clinical Trials as Topic / Q000379:methods*; D018450:Disease Progression; D015195:Drug Design; D017408:Guidelines as Topic; D006801:Humans; D008568:Memory; D008954:Models, Biological; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D012720:Severity of Illness Index; D016896:Treatment Outcome
D015415:Biomarkers